PCIBo — PCI Biotech Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK6.07m
- -NOK7.27m
- NOK6.74m
Brief: PCI Biotech Initiates Research Collaboration With IMV Inc
Brief: PCI Biotech Holding Q1 Pre-Tax Loss Widens To NOK 14.5 Million
Norway's PCI Biotech sees promising data from cancer drug study - CEO (updated)
Norway's PCI Biotech sees promising data ahead of key study -CEO
Brief: PCI Biotech Holding Requests Transfer Of Listing From Oslo Axess To Oslo Børs
Brief: PCI Biotech Holding Extends Preclinical Research Collaboration
Brief: PCI Biotech Q3 Operating Loss NOK 10.5 Mln
Brief: PCI Biotech granted orphan drug designation from FDA for Fimaporfin
Brief: PCI Biotech: initial results from fimaVACC Phase I
Brief: PCI Biotech Q2 oper loss narrows to NOK 7.2 million
Brief: PCI Biotech: extension of preclinical research collaboration agreement
Brief: PCI Biotech Q4 operating loss lowers to NOK 6.9 million
Brief: PCI Biotech gets NOK 13.8 mln to further development of PCI for use in vaccination
Brief: PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway
Brief: PCI Biotech rights issue oversubscribed by about 109 pct
Brief: PCI Biotech extends existing collaboration agreement
Brief: PCI Biotech and Etherna Immunotherapies start research collaboration
Brief: PCI Biotech Holding Q3 operating loss flat at NOK 9.5 mln
Brief: PCI Biotech proposes fully underwritten rights issue of NOK 70 mln